StemCell Institute Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	2,783	2,679	2,481	2,091	1,781	1,409
Revenue Growth (YoY)	5.54%	7.98%	18.65%	17.41%	26.40%	-15.93%
Cost of Revenue	1,067	987	905	755	670	485
Gross Profit	1,716	1,692	1,576	1,336	1,111	924
Selling, General & Admin	1,414	1,250	1,142	1,024	874	829
Operating Expenses	1,437	1,273	1,162	1,038	884	837
Operating Income	279	419	414	298	227	87
Interest Expense	-4	-1	-	-	-	-
Interest & Investment Income	19	10	3	1	-	-
Other Non Operating Income (Expenses)	-5	-	-1	-	-16	4
EBT Excluding Unusual Items	289	428	416	299	211	91
Gain (Loss) on Sale of Investments	-	136	22	-	-	-
Other Unusual Items	-	-	2	-21	-	-
Pretax Income	289	564	440	278	211	91
Income Tax Expense	99	179	130	80	78	29
Net Income	192	385	310	198	133	62
Net Income to Common	192	385	310	198	133	62
Net Income Growth	-51.39%	24.19%	56.57%	48.87%	114.52%	-77.62%
Shares Outstanding (Basic)	10	10	10	10	5	5
Shares Outstanding (Diluted)	10	10	10	10	5	5
Shares Change (YoY)	-1.06%	-0.05%	-	102.33%	4.05%	-
EPS (Basic)	18.94	37.59	30.25	19.32	26.26	12.74
EPS (Diluted)	18.94	37.59	30.25	19.32	26.26	12.74
EPS Growth	-50.87%	24.25%	56.57%	-26.42%	106.16%	-77.62%
Free Cash Flow	-	-11	151	43	288	-164
Free Cash Flow Per Share	-	-1.07	14.74	4.20	56.87	-33.70
Gross Margin	61.66%	63.16%	63.52%	63.89%	62.38%	65.58%
Operating Margin	10.03%	15.64%	16.69%	14.25%	12.75%	6.17%
Profit Margin	6.90%	14.37%	12.50%	9.47%	7.47%	4.40%
Free Cash Flow Margin	-	-0.41%	6.09%	2.06%	16.17%	-11.64%
EBITDA	413	547	534	402	323	119
EBITDA Margin	14.84%	20.42%	21.52%	19.23%	18.14%	8.45%
D&A For EBITDA	134	128	120	104	96	32
EBIT	279	419	414	298	227	87
EBIT Margin	10.03%	15.64%	16.69%	14.25%	12.75%	6.17%
Effective Tax Rate	34.26%	31.74%	29.54%	28.78%	36.97%	31.87%
Advertising Expenses	-	221	196	194	175	166

Source: S&P Global Market Intelligence. Standard template. Financial Sources.